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Syntaxin 1ABinding of speciﬁc lipids to large, polytopic membrane proteins is well described, and it is clear that such lipids
are crucial for protein stability and activity. In contrast, binding of deﬁned lipid species to individual transmem-
brane helices and regulation of transmembrane helix monomer–oligomer equilibria by binding of distinct lipids
is a concept, which has emerged only lately. Lipids bind to single-span membrane proteins, both in the juxta-
membrane region aswell as in the hydrophobicmembrane core.While some interactions counteract transmem-
brane helix oligomerization, in other cases lipid binding appears to enhance oligomerization. As reversible
oligomerization is involved in activation of many membrane proteins, binding of deﬁned lipids to single-span
transmembrane proteins might be a mechanism to regulate and/or ﬁne-tune the protein activity. But how
could lipid binding trigger the activity of a protein? How can binding of a single lipid molecule to a transmem-
brane helix affect the structure of a transmembrane helix oligomer, and consequently its signaling state? These
questions are discussed in the present article based on recent results obtained with simple, single-span trans-
membrane proteins. This article is part of a Special Issue entitled: Lipid–protein interactions.
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eider).1. Dimerization of TM helices regulates cellular functions
Folding of large, polytopic transmembrane (TM) proteins in-
volves interactions of multiple TM helices, and thus individual TM
helix–helix interactions can affect or even dictate the assembly of
large protein complexes [1–4]. In fact, altered interaction propensi-
ties of individual TM helices might be linked to various diseases,
due to destabilization or misfolding of polytopic TM proteins [4–6].
However, almost half of the whole human TM proteome consists of
single-span TM proteins [7,8]. Single-spanning membrane proteins
(MPs) mediate a wide range of cellular processes, including cell–cell
adhesion (integrins) [9,10], immune recognition (major histocompati-
bility complex, MHC) [11] and signal transduction (e.g., receptor
Fig. 1.How the lipid environment can affect TMprotein structures. Non-annular lipids (or-
ange) bind speciﬁcally at the surface of TM proteins via salt bridges between charged lipid
head groups and charged residues at the membrane-water interface (black arrows). Hy-
drophobic, Van der Waals and weak dipolar interactions might additionally be involved
in lipid binding. Van der Waals interactions between the acyl chain and hydrophobic
amino acids further contribute to tight lipid binding (purple arrows). Bulk lipids deﬁne
the global membrane environment of TM proteins and affect membrane protein folding
viamembrane properties, such as the hydrophobic thickness (green arrow) and the lateral
membrane pressure proﬁle (blue arrow). The geometry of the lipids (bilayer-forming vs.
non-bilayer-forming) as well as electrostatic interactions between the lipid head groups
(black arrows) and packing of the lipid acyl chains determine the global membrane
properties.
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MPs are common [13,14]. Importantly, the TM helices that anchor
MPs in the membrane are often critically involved in oligomerization
of the full-length MPs. While strongly associating single-span TM heli-
ces are thought to form stable membrane-inserted protein–protein
complexes, modestly strong interacting TM helices exist in a dynamic
equilibriumof the freemonomers and the associated oligomers. Revers-
ible oligomerization of individual TM helices can trigger and regulate
signaling processes at and across cellular membranes. E.g.,while dimer-
ization of the various integrin α- and β-subunits is not completely
understood, the respective TM domains are most likely crucially in-
volved in integrin dimerization, and it has been shown that integrin
TMdomain interactions trigger integrin functions [15–19]. The immune
active MHC class II complex is formed by an α/β-heterodimer and in-
variant chain proteins. Recent results also indicate that here TM helix–
helix contacts are crucial for formation of the MHC II complex [20].
RTKs form dimers or even higher-ordered multimeric complexes, and
a plethora of data has demonstrated in recent years that dimerization
and activation of RTK-family members are mediated by the single TM
helix [21–26]. In line with this, the isolated single-span TM domains
of all human RTKs have been shown to have an intrinsic propensity to
interact, and thus oligomerization of RTK TMhelices appears to be com-
mon [27]. In the case of ErbB (HER) proteins, probably the best charac-
terized RTK-family members, deﬁned adjustments of the TM helix
dimer structure appear to be involved in signaling [21,28]. A recent
analysis of the human single-span TM proteome has revealed that the
isolated TM helices of many single-span TM proteins have an intrinsic
propensity to form higher ordered oligomeric structures [14], and
thus oligomerization of single-span TM proteins appears to be the rule
rather than the exception.
Molecular forces driving interactions of single- and multi-span TM
proteins within the membrane include Van der Waals interactions,
resulting from close packing of interacting helices, hydrogen bonding,
as well as ionic and aromatic interactions [5,29–31]. That formation of
tightly packed, homo-oligomeric helix bundles is driven by sequence-
speciﬁc interaction of TM helices was demonstrated more than
25 years ago for the TMdomain of the human glycophorin A (GpA) pro-
tein [32], amembrane integral protein located in the red blood cell plas-
ma membrane. Later, seven amino acids of the LIxxGVxxGVxxT-motif
were identiﬁed in a mutational study to be involved in dimerization
[33–35]. The GxxxG-core of the GpA interaction motif turned out to be
highly overrepresented in TMproteins and still represents themost sig-
niﬁcant motif in interacting TM helices identiﬁed thus far [36,37]. Be-
sides this, several motifs mediating oligomerization of TM domains
have been identiﬁed, including Ser and/or Thr-containing motifs [38,
39], motifs containing aromatic residues [40,41] or residues with
carboxamide side chains [42–47], as well as the QxxS-motif [48,49].
More than onedozen high-resolution structures of simple TMhelix olig-
omers have been published in recent years, revealing deﬁned helix–
helix contact interfaces. However, often no deﬁned interaction motifs
have been identiﬁed, and two TM helices interact by forming comple-
mentary surfaces, which allow close helix packing, as summarized re-
cently in Cymer et al. [30]. However, since reversible interactions of
TM helices might be involved in inhibition or activation of the full-
length proteins, TM helix oligomerization has to be regulated to avoid
constitutive activation or inhibition of the proteins. Formation and sta-
bility of TM helix bundles are not only deﬁned by the speciﬁc amino
acid context, but also by the composition of the intimate lipid environ-
ment, aswell as by the overall physico-chemical properties of themem-
brane. MPs communicate with the lipid environment and thereby the
association and activity of MPs might be manipulated and/or triggered.
2. Lipids interact with membrane proteins
Eukaryotic membranes are composed of diverse phospholipids with
different head groups and acyl chain lengths as well as cholesterol [50].It is not ﬁnally resolved yet why membrane lipids have different acyl
chain lengths. Possibly, it is important for grouping proteins and lipids
with similar hydrophobic thicknesses, as hydrophobic regions of TMdo-
mains also differ in their length in MPs. In fact, based on the OMP data-
base [51], the hydrophobic thickness of dimeric single-span human TM
proteins found in the human plasma membrane varies between 30 and
36 Å, which strongly indicates that the thickness of the lipid bilayer lo-
cally adjusts to completely mask the hydrophobic region. Hydrophobic
mismatch conditions can result in protein aggregation within lipid bi-
layer environments [52–56].
Besides the hydrophobic thickness of the membrane, the lateral
pressure proﬁle within the acyl chain region as well as the distribution
of lipid head group charges at a protein–lipid interface control interac-
tions of MPs with lipids [30,57–59]. In general, lipid binding to a MP
can be stabilized by electrostatic and hydrophobic interactions between
the lipid head groups and amino acid residues and additionally by a
large number of hydrophobic interactions between the hydrophobic
lipid tails and TMmoieties of the protein (Fig. 1).
Based on the residence time of a particular lipid at the lipid–MP
interface, three types of interactions of lipids with MPs might be dis-
tinguished (Fig. 2) [60]. Lipids, which diffuse rapidly within the bi-
layer plane and show a low residence time at the protein–lipid
interface, so-called bulk lipids, do not directly affect the structure
and/or function of MPs. The bulk lipid phase represents the total
lipid volume of the membrane and determines its global characteris-
tics, such as the membrane ﬂuidity, the lateral pressure, the bilayer
thickness or the membrane surface charge. When the polar lipid
head group interacts with a MP or when hydrophobic matching be-
tween the lipids and the TM domain of the MP is crucial, the resi-
dence time of the lipids might signiﬁcantly increase and a shell of
annular lipids is formed around the MP. The composition of this
annular lipid shell is determined by the local architecture of the pro-
tein. In the annular lipid shell, which is composed of around 50–100
lipids and which is not necessarily homogeneous [61], the speciﬁc
characteristics of the lipids can strongly affect the structure and
function of a MP [62,63].
If the interaction of lipids and MPs is even stronger, the so-called
non-annular surface lipids will bind speciﬁcally and tightly to MPs, typ-
ically in cavities and clefts of hydrophobic binding pockets [64]. Non-
annular lipids often remain bound toMPs, even if theMPswere puriﬁed
and crystallized in detergent [65,66]. Especially in larger protein com-
plexes, non-annular lipids ﬁll the crevices between adjacent monomers
or subunits and thereby mediate protein complex formation. These
lipids seem to play an important role in the structural stability of MPs,
and tightly bound lipids can be essential for the activity of MPs [67].
Fig. 2. Intramembrane protein–lipid interactions— a top view on the membrane. A mem-
brane protein dimer stabilized by tightly bound non-annular lipids. Non-annular lipids ﬁt
into cavities at the protein surface, and these lipids are often found to be still bound in iso-
lated proteins. A belt of annular lipids deﬁne the intimate environment of a membrane
protein.While the structure and size of this lipid belt varies, itwas suggested that a protein
is typically surrounded by 50–100 annular lipids [61]. Annular lipids havehigher exchange
rates at themembrane protein than non-annular lipids, but the diffusion rate of the annu-
lar lipids is signiﬁcantly reduced compared to the bulk lipid phase. Lipidswith low degree
of interaction with the TM protein are considered to be “bulk” lipids, which have high lat-
eral displacement and diffusion rates.
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which is only active when negatively charged lipids are bound
[68–70], and ADP/ATP carriers require binding of cardiolipins (com-
pare Fig. 3) for activity [71,72]. More examples and detailed informa-
tion on how non-annular lipids affect MPs' activities can be found in
Lee et al. [62].
Cholesterol binding to MPs has been studied to a great extent in re-
cent years. A cholesterol-binding motif was initially identiﬁed in the
peripheral-type benzodiazepine receptor [73] (Table 1). The CRAC
(Cholesterol Recognition Amino acid Consensus) motif (L/V-(x)1–5-Y-
(x)1–5-R/K), where x represents an arbitrary amino acid, consists of
hydrophobic, aromatic and positively charged amino acids. Later, the
reversed motif (CARC-motif, K/R-(x)1–5-Y-(x)1–5-L/V) (Table 1) was
postulated to be important for cholesterol binding [74]. In general, bind-
ing of cholesterol appears to require the presence of a polar amino acid
that is able to hydrogen bond to the 3β-OH group of cholesterol (com-
pare Fig. 3), as well as small hydrophobic as well as aromatic amino
acids that are involved in hydrophobic and π–π stacking interactions
at the lipid–protein interface [75]. However, the interaction of CRAC
and CARC motifs with cholesterol remains unclear, and the currently
available MP X-ray structures do not indicate that any distinct amino
acid motif mediates cholesterol binding to MPs [67]. Furthermore, the
CRAC motif has been identiﬁed more than 5000 times in the proteome
(2100 proteins) of a cholesterol-free bacterium [76], and thus the pre-
diction value of cholesterol-binding sites, using these motifs, appears
to be very low. Furthermore, cholesterol, one of the best studied lipids
in biochemical andmedical research, has a dramatically different struc-
ture than typical bilayer-forming diacyl phospholipids (Fig. 3). Thus,
cholesterol binding might be rather speciﬁc.2.1. Binding to negatively charged lipid head groups can control TM peptide
oligomerization and clustering
The impact of global bilayer properties on the oligomerization of
TM helices has already been analyzed to some extent, and single-
span TM helices frequently serve as manageable models to reveal
the impact of the lipid bilayer on a MP structure. While binding of
speciﬁc non-annular lipids to polytopic TM proteins has been identi-
ﬁed and analyzed to some degree in the past, recent work has also
identiﬁed lipid-recognition by single-span TM helices, and lipid
binding appears to severely affect protein folding as well as the cel-
lular functions of the proteins (as further discussed below).
The GpA TM helix dimer has for a long time served as a paradigm in
studies, aiming at identifying sequence determinants in a TM helix–
helix interaction. Several recent in vitro studies have shown that the
detergent environment can severely affect TM helix dimerization pro-
pensities of GpA and other dimerizing TM helices [77–85]. Global lipid
bilayer properties, such as the order of the lipid acyl chains or the
membrane thickness, also affect the structure of the GpA TM helix in
membranes [86–88]. Furthermore, in model membrane systems, the
anionic lipids phosphatidylglycerol (PG) and phosphatidylserine (PS)
(compare Fig. 3) severely destabilize the GpA TM helix dimer [89]. The
negatively charged lipid head groups appear to speciﬁcally bind at the
juxtamembrane region to a stretch of basic amino acids, which follow
the C-terminus of the GpA TM helix [89]. Binding of the negatively
charged lipids destabilized the GpA helix dimer, although it is currently
unclear how the TM helix dimer structure is weakened. How is the
signal “bound lipid” transferred from the juxtamembrane region to
the TM helix–helix interface, resulting in TM helix dimer destabiliza-
tion? Is this deleterious effect merely based on the negative net
charges of the lipids but not on the acyl chains? And, if solely the neg-
ative charge matters, how do even more negatively charged lipids,
such as phosphatidylinositol phosphates, affect the structure of olig-
omeric single-span MPs after binding?
Phosphatidylinositol 4,5-bisphosphate (PIP2) is the most abundant
PI in mammalian plasma membranes, with about 1% of the total
lipid located in the inner leaﬂet of the membrane [90,91]. PIPs are
lipids with an inositol head group conjugated with three phosphate
groups (Fig. 3). The phosphate at the ﬁrst carbon atom is esteriﬁed
with glycerol that carries two fatty acid residues. PIP2 with its two
phosphate groups at carbon atoms four and ﬁve is e.g., a substrate
of phospholipase C (PLC), controlling downstream signaling cas-
cades [92,93]. Furthermore, PIP2, as well as its phosphorylated form
PIP3, can also directly act as a docking lipid for enzymes, thereby
recruiting proteins to the plasma membrane [91,94]. PIP2 electrostati-
cally interacts via its negatively charged phosphate groups with non-
contiguous basic residue-rich clusters at proteins [91,95]. The PIP phos-
phates at positions four and ﬁve form several hydrogen bonds with
residues in the PLC pleckstrin homology (PH) domain, and especially
electrostatic interactions with two lysine residues fasten the protein at
the membrane surface [96,97]. However, N250 other identiﬁed PH do-
mains only weakly interact with inositides, rendering lipid binding ex-
clusively to the PLC PH domain unlikely. Besides the PH domain, other
PIP2 binding domains exist in soluble proteins, as discussed in greater
detail in recent reviews [91,95,98]. However, are PIP2 binding domains
also present in integral MPs? In fact, the K+ channel Kir2.1 requires
binding of multiple PIP2-molecules for channel activity. Here, PIP2 elec-
trostatically interacts with three independent sites at the channels' C-
terminus, thereby stabilizing an active channel conformation [99].
While the TMdomain appears to bind any diacylglycerolwith a 1′ phos-
phate, the juxtamembrane region speciﬁcally interacts only with the
PIP2 head group and thereby deﬁnes the lipid-binding speciﬁcity. Im-
portantly, while PIP2-binding does not change the tetrameric assembly
of the related Kir2.2 channel, lipid binding induces a conformational
change in a ﬂexible linker region, which results in reorganization of
the entire channel structure and ﬁnally in channel activation [100].
Fig. 3.Chemical structures of lipids. Depicted are the lipid species discussed in this article. PG: phosphatidylglycerol, PS: phosphatidylserine, SM: sphingomyelin, PIP2: phosphatidylinositol
4,5-bisphosphate, PIP3: phosphatidylinositol-3,4,5-trisphosphate, Chol: cholesterol, CL: cardiolipin. Typical n-values of the discussed phospholipids vary between 12 and 18. In the case of
the SM C18:0 sphingomyelin species discussed in the text, the fatty acid chain carries 18 carbon atoms. Not shown is ceramide, which is SM without the phosphocholine head group
(boxed).
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several studies showed a co-localization of syntaxin 1A with such
PIP2 clusters, indicating that PIP2 is required for syntaxin clustering
[101–103]. The membrane target SNARE (tSNARE) syntaxin 1A is com-
posed of a N-terminal three-helix bundle Habc, an amphipathic helix H3
that interacts with other SNARE proteins to form a fusion complex (or
the Habc domain), and a C-terminal TM domain [104–107]. Interaction
of PIP2 with the single TM helix of syntaxin 1A leads to sequestration
of the protein and the lipid [102]. Even though it is much less abundant
than PIP2 in cellular membranes, PIP3 is also important for syntaxin 1A
clustering and the function of the SNAP–SNARE complex [94]. The inter-
action of syntaxin 1A with PIP lipids is mediated by a stretch of basic
amino acids. The critical residues are directly adjacent to the TM helix
and are in contact with the lipid head groups [108,109]. The positive-
ly charged residues of the 260KARRKK265 amino acid motif interact
with PIP2 (Fig. 4), and a strong reduction of the lipid–protein interac-
tion was observed when Lys264 and/or Lys265 were mutated to Ala
[102]. Mutation of the wt syntaxin 1A sequence also led to reduced
vesicle fusion in cells, which additionally demonstrates the in vivoTable 1
Lipid binding motifs identiﬁed in membrane integrated proteins.
Motif Bound lipid aa sequence
CRAC Cholesterol L/V-(x)1–5-Y-(x)1–5-K/R
CARC Cholesterol K/R-(x)1–5-Y/F-(x)1–5-L/V
CCM Cholesterol Formed by helices 1–4a
[4.39–4.43 (R,K)]–[4.50 (W,Y
Tilted peptides Cholesterol ExxxxNxGxxxGxxxGG
SBD Glycosphingolipid Loop: aromatic AAs + basic A
Sphingomyelin C18:0 VxxTLxxIY
PIP binding motif Phosphatidylinositol-phosphates KARRKK
For further information and examples see reviews [64,189].
a Numbering based on the Ballesteros–Weinstein. x = apolar aa-residue.importance of the basic amino acids and of PIP binding [110]. PIP3
binds even more efﬁciently to syntaxin 1A and can replace PIP2 at the
interaction site, also mediated by electrostatic interactions with the
above-mentioned stretch of positively charged amino acids [94]. Re-
cently, PIP3 has been identiﬁed as an inducer of syntaxin 1A clustering
in cellular membranes [94], and the concomitant mutation of Lys264
and Lys265 abolished PIP3-syntaxin 1A clustering. These data indicate
that mainly electrostatic interactions stabilize the binding of PIPs to
syntaxin 1A, due to the strong negative net charge of the lipid head
groups. As also observed in the case of the Kir2 K+ channels, no further
structural prerequisites for PIP binding to syntaxin 1A have been de-
scribed yet. Additionally, as PS, with its one net negative charge, does
not induce syntaxin 1A clustering, even in the presence of 20% PS
[94], not only the negative head group charge but also the chemistry
of the lipid head group might matter. Furthermore, the entropy cost
for binding two or three lipids via electrostatic interactions is much
higher than binding a single lipid with multiple charges, so that
binding of PIP3, with its four negative charges, might be preferred
over PIP2 or PS. PIPs mediate syntaxin 1A clustering, and additionallyFirst identiﬁed Ref.
P-type benzodiazepine receptor [73,185]
Nicotinic acetylcholine receptor [74,185]
)]–[4.46 (I,V,L)]–[2.41 (F,Y)]
β2-adrenergic receptor [185,186]
C99 [146,185,187]
A in proximity HIV gp120, APP [124,128]
p24 [123,130]
Syntaxin 1A [94,102,188]
Fig. 4. The syntaxin 1A transmembrane helix. (A) Amino acid sequence of the syntaxin 1A
TM region. The TM domain is underlined. (B) Surface structure of the syntaxin 1A helix.
(C) Rotated syntaxin structure (~180°). (B, C): PDB ID: 2M8R. Residues involved in lipid
(PIP) binding are highlighted in orange, whereas residues triggering dimerization of the
TM helices are depicted in blue.
Fig. 5. The p24 TMhelix. (A) Amino acid sequence of the p24 TM region. The TMdomain is
underlined. (B) Structure of the p24 TM helix. The structure was modeled using the PEP-
FOLD Peptide Structure Prediction Server [190–192]. Residues involved in lipid (SM18:0)
binding are highlighted in orange.
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mediating homodimerization of syntaxin and heterodimerization
with its natural interaction partner synaptobrevin II are Met267,
Cys271 and Ile279 [112] (Fig. 4). Looking at the NMR structure of
syntaxin 1A, the β-branched Ile residues 266, 270, 277 (possibly
also Val273) form a smooth and very hydrophobic surface at one
side of the syntaxin 1A TM helix (Fig. 4). These residues are most
likely not involved in dimerization of syntaxin 1A, and thus they
might additionally stabilize PIP2 binding via hydrophobic interac-
tions between the lipid acyl chains and the hydrophobic TM surface.
However, such an assumption has to be tested in future experiments.
2.2. Sphingomyelin binding to the transmembrane helix triggers
oligomerization of the COP I machinery protein p24
Formation of COP I and COP II complexes is a crucial step in the trans-
port of proteins between the endoplasmic reticulum (ER) and the Golgi
apparatus in eukaryotic cells. COP I is involved in the anterograde vesi-
cle transport from the ER to the Golgi, whereas COP II vesicles are in-
volved in the retrograde transport from the Golgi to the ER [113,114].
For traveling between these compartments, both pathways depend on
immobilization of coat complexes at the vesicular surface. Coat complex
formation at the vesicle surface is mastered by a type-I TM protein with
a mass of ~24 kDa, hence the name p24. Potential roles for p24 proteins
in cargo reception and coat recruitment are discussed in Strating et al.
[115]. The p24 protein family can be subdivided into four subfamilies
(α, β, γ, δ) [116]. However, the bewildering variety of names of several
members of the p24 family makes it difﬁcult to identify the protein of
interest [115]. The p24 protein we discuss here is the protein p24β1,
or TMED2, or p24 or p24a and will further just be called p24.
All p24 proteins share a similar structural arrangement. A large glob-
ular N-terminal GOLD (Golgi dynamic) domain [117] is located at the
luminal side of themembrane. The exact function of this domain is enig-
matic but it co-occurs with lipid-, sterol- or fatty acid-binding domains,
such as PH, Sec14p, FYVE and RUN [117]. The GOLD domain is followed
by an undeﬁned coiled-coil region, a TMα-helix and a short C-terminal
cytoplasmic tail, which is involved in COP I and COP II coat complex
binding [115,118]. p24 proteins are known to form homo- and hetero-
dimers, depending on their localization [119]. An involvement of thecoiled-coil [120] and the cytoplasmic region in p24 dimerization is
discussed [121,122], albeit recent results suggest that TMhelix–helix in-
teractions mediate dimerization of p24, triggered by binding of a
sphingolipid [123].
Sphingolipid-binding motifs were initially identiﬁed in HIV-1
virus and amyloid proteins (Table 1) [124–127]. The identiﬁed
motif is part of a hairpin structure of the gp120 protein at the surface
of HIV-1 and Alzheimer-β-amyloid peptides. The aromatic residues Tyr,
Trp and Phe are part of the sphingolipid-binding domain (SBD) and the
glycosphingolipids aremainly bound viaπ-stacking and electrostatic in-
teractions with the sugar head groups. These interactions are accompa-
nied by structural rearrangements of both binding partners [128]. The
interactionmotif, which has also been identiﬁed in the serotonin recep-
tor family and can be predicted in several other MPs [128,129], binds
glycosylated sphingolipid species restrictively.
p24 selectively binds a single sphingomyelin (SM) species, SM C18:0,
but not ceramide (lacking choline head group) or phosphocholine ana-
logs (Fig. 3) [123]. Further analyses revealed a remarkable preference
of p24 to bind C18:0 SM, and shorter or longer chain length SMs appear
to not interact with the p24 TM domain [123]. Thus, p24 preferentially
binds sphingomyelins and both the head group, aswell as the hydropho-
bic acyl chain regions of the lipids are important. As the head group of
phosphatidylcholine and SM is identical, the hydrophobic acyl chain re-
gion is supposed to determine the speciﬁc binding of SM derivatives to
the p24 TM helix. To identify amino acids involved in lipid binding,
each residue of the p24 TM domain was mutated to Ala and SM binding
was analyzed. Based on this analysis, a VxxTLxxIY amino acidmotif in the
TM helix determines SM binding to p24 (Table 1). Molecular modeling
has indicated that SM C18:0 ﬁts perfectly into a cavity formed by the res-
idues Val13, Thr16 and Leu17 (Fig. 5) [123]. Mutation of a single residue in
this cavity to an amino acid with a bulky side chain in fact completely
abolished SM binding [123]. However, it was suggested that the lipid
head group too is important for binding since the structurally similar cer-
amide did not interact with p24. Unfortunately, the described binding
motif only covers the TM helix. It is very likely that electrostatic interac-
tions between the protein and the sphingolipid head group also play a
role in lipid binding, as e.g., described above concerning syntaxin 1A. In
the case of p24, only a few amino acids are available for interactions, as
the C-terminus, attached to the sphingolipid-binding site, is very short
Fig. 6. The TM protein C99. (A) Amino acid sequence of the C99 protein. The TM domain is
underlined. (B) C99 structure determined in lyso-myristoylphosphatidylglycerol detergent
micelles by nuclear magnetic resonance (NMR) spectroscopy at pH 6.5 (PDB ID: 2LP1).
(C). C99 structure determined in dodecylphosphocholine detergent micelles by NMR spec-
troscopy at pH4.3–5.3 (PDB ID: 2LLM). In both structures theN-helix andN-loop are labeled,
which can rotate freely as their relative position to the TMhelix is random in different calcu-
lated conformers. The TM helix appears to be more kinked in the 2LP1 structure (B). Resi-
dues involved in lipid (cholesterol) binding are highlighted in orange. Amino acids
involved in both lipid binding and TM helix dimerization are depicted in green.
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sphingolipids also bind to G-protein-coupled receptors (GPCRs), mediat-
ed by an amino acidmotif, similar to the p24 sphingolipid-bindingmotif,
and sphingolipid binding to a single TM helix of the receptor might sta-
bilize different GPCR conformations [130].
As mentioned, p24 is able to form homo- or hetero-dimers with
other proteins of the p24 family, which is a crucial step in COP vesicle
formation. However, dimerization of p24 appears to be linked to
sphingolipid binding. In SM C18:0 containing liposomes, p24 homo-
dimerization is signiﬁcantly increased, whereas a SM-binding deﬁcient
mutant has a decreased dimerization propensity, even in the presence
of SM C18:0. Unfortunately, the dimerization interface in the p24 TM
helix has not been described yet, although a molecular dynamics simu-
lation study suggests a rather polar dimerization interface, which does
not overlap with the sphingomyelin binding site [123].
It is suggested that the dimeric p24 family proteins immobilize
the COP complex at themembrane surface. However, the SM concen-
trations, which could severely modulate dimerization of p24, signif-
icantly differ from the ER to the Golgi and the plasma membrane.
Thus, the sphingolipid concentration within a given organelle mem-
brane might directly inﬂuence the secretory pathway by triggering
the oligomeric state of p24. However, the heterogeneous distribu-
tion of SMwithin a single membrane further complicates such an in-
terpretation, as sphingolipids and cholesterol can form speciﬁc lipid
microdomains in cellular membranes [131–137].
2.3. C99, the β-secretase cleavage product of the amyloid precursor protein
APP speciﬁcally binds cholesterol
The TM protein C99, also known as β-CTF, is a key protein in the
amyloidogenic pathway. It is associated with the release of amyloid
β-peptides and therefore represents a key protein in the develop-
ment of Alzheimer's disease [138–141]. C99 is produced by the
amyloidogenic cleavage of the full-length amyloid precursor protein
APP, catalyzed by the β-secretase [141]. This cleavage generates the
99-amino-acid-long single-spanning TM protein C99, which is then
cleaved inside the membrane by the γ-secretase to release amyloid-β
peptides [142,143]. The structure of themonomeric as well as of the di-
meric C99 has been determined byNMR inmicellar solutions [144–146]
(Fig. 6). An extracellular N-terminus is followed by a surface-attached
helix (N-helix) (residues 688–694) and a ﬂexible loop (N-loop) (resi-
dues 695–699). The highly curved TM helix (residues 700–723) is
kinked close to the center of the micelle, near Gly708 and Gly709. This
might be related to the processive cleavage by the γ-secretase, as ﬂexi-
bility allows the helix to adopt to the sluice-like active site of the prote-
ase [146–149]. Importantly, the proteolytic efﬁciency is enhanced 2–4
fold in the presence of cholesterol [150].
In recent studies a cholesterol-binding site and a homodimerization
interface at C99 were deﬁned [146,151–153]. Homodimerization and
cholesterol binding were found to compete, as both involve the glycine
zipper motif G700xxxG704xxxG708G709 [151] (Fig. 6A). Especially the
GxxxG-motifs were expected to promote tight packing of two adjacent
C99 TM α-helices, resulting in Van der Waals packing interactions and
potentially in formation of Cα hydrogen bonds, as demonstrated for
other TM proteins [3,103,154,155]. Indeed, both APP as well as the
C99 fragment were found to dimerize, and dimerization is mediated
by the GxxxG-motif [110,144,145,156–159]. The isolated C99 TM helix
was found to oligomerize strongly in a bacterial membrane when mea-
sured with the ToxR-system, and oligomerization was impaired when
critical Gly residues of a GxxxG-motif were replaced [110]. Based on
the current available data, the β-secretase cleavage product of APP,
C99, forms a stable dimer, stabilized by the glycine zipper motif located
in the TM domain.
However, the physiological relevance of C99 dimerization is still a
matter of debate [151]. In fact, the equilibrium dissociation constant
for the dimer was determined to be in the range of 0.5 mol%, indicatingthat the protein appears to bemainly monomeric at a C99-to-lipid ratio
of 1:200. While the exact C99 concentration has not been quantiﬁed in
eukaryotic cells, the concentration of the amyloid precursor protein APP
in neuronal membranes is in the range of 10−3–10−4 mol% [159].
Therefore, C99 might be mostly monomeric under physiological condi-
tions, while it cannot be ruled out that C99 exceeds the concentration of
0.5mol% in heterogenicmembranes and deﬁned lipid domains,where it
possibly forms dimers. Recently, the protein and lipid composition of a
synaptic vesicle has been determined [160], and here on average
about 600 TM domains together with ~7000 phospholipids and ~5000
cholesterol molecules form the vesicle membrane. About one quarter
of themembrane volume is represented by the TM domains, and as an-
nular lipids bind more tightly to the TM domains, only a minor fraction
of the lipids is expected to be free. At a TM helix-to-lipid ratio of ~1:20,
as determined in this study, a signiﬁcant fraction of the C99 TM domain
might be dimeric.
Cholesterol, which is crucial for the formation of lipid domains [161],
is suspected to be involved in the development of Alzheimer's disease,
as neuronal cholesterol levels increase the production of amyloid-β
peptides. Both APP as well as solely the C99 fragment can speciﬁcally
bind cholesterol, and consequently the C99 TM region is responsible
for cholesterol attraction, while the N-terminal C99 extra-membrane
domain contributes to formation of the lipid-binding site [146,151,
156]. The determined equilibrium dissociation constant for cholesterol
binding (~3 mol%) is on the low end of the physiological cholesterol
concentration in mammalian cells [50,151]. The level of cholesterol in
membranes of animal cells can make up to 50 mol% of the membrane
lipid content but varies between membrane systems and tissues. The
ER and nuclear membrane usually contain 1-10 mol% cholesterol,
which increases to about 10-25 mol% in Golgi stacks and 30–40% in
the plasma membrane [50,162–169]. Thus, cholesterol is most likely
tightly bound to C99 under physiological conditions. But where and
how does cholesterol bind to the short C99 peptide? Previous studies
suggested a possible lipid-binding site around the N-helix/N-loop/TM
domain element [145,170]. Due to the trans ring junctions, cholesterol
is a ﬂat molecule (Fig. 3), and binding of the rigid cholesterol to the
TMhelix is generally expected to be entropically favored over an associ-
ation of the helix with more ﬂexible diacyl phospholipids. One face of
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yl groups (C18, C19), resulting in a rough side. Interestingly, residues
Gly700, Gly704 and Gly708 of the TM domain, which have been shown
to play a crucial role in C99 homooligomerization, appear to be involved
in formation of the cholesterol-binding site (Table 1 and Fig. 6), suggest-
ing a competition of homodimerization and cholesterol binding at the
glycine zipper motif [151]. The tandem GxxxG motif (+GxxxA) on
the C99 TM helix provides a large ﬂat surface spanning over about
three helix turns near the extracellular space, which is well-suited to in-
teract with the cholesterol molecule, allowing Van der Waals interac-
tions between the lipid ring system and the TM helix. Cholesterol
binds with its relatively rough β-face to the TM domain, whereas the
smooth α-face is oriented towards the surrounding lipids. The two
methyl groups of the β-face might intrude in protein cavities, resulting
in tighter binding [162]. Binding of cholesterol might be further en-
hanced by hydrogen bond formation between Glu693 and Asn698 of
the N-loop and the N-helix, respectively, with the 3β-OH-group of cho-
lesterol. To optimize the interaction of cholesterol with the soluble re-
gions of C99, a certain ﬂexibility of the N-Loop is given, which allows
the N-helix to rotate and to adapt a suitable position to interact with
the cholesterol molecule in an induced-ﬁt clamp-like manner [146].
Noteworthy, residues involved in cholesterol binding to C99 are differ-
ent from postulated cholesterol-binding motifs found in other proteins
(CRAC, CARC, CCM) [75,162]. Together, these results indicate that cho-
lesterol binding of C99 depends on (i) the tandem GxxxG motif near
themembrane surface, providing aﬂat attachment surface, (ii) aﬂexible
loop at the membrane water interface and (iii) hydrogen bond
formation between amino acids in the soluble region of the MP and
the 3β-OH-group of cholesterol. In the presence of cholesterol, C99
preferentially interacts with cholesterol rather than with a second
monomer to form a homodimer [151]. As the dimerization propensity
of C99 is supposed to be low under physiological conditions, and as
the interfaces for cholesterol binding and homodimerization highly
overlap, cholesterol binding directly competes with TM helix dimeriza-
tion [151].
However, does cholesterol binding to C99 have an effect on the pro-
teolytic cleavage by theγ-secretase?Numerous reports associateβ- and
γ-secretase with cholesterol-rich lipid phases inmembranes, where the
amyloidogenic pathway is active [171–178]. The α-secretase, which is
responsible for the non-amyloidogenic pathway, resides in the bulk
membrane phase, indicating a speciﬁc cholesterol dependence of the
amyloidogenic pathway [68,179]. Proteolytic cleavage of C99 by the γ-
secretase is dramatically enhanced in cholesterol-containing mem-
branes [150]. Whether cholesterol is bound to C99 during the cleavage
process remains an open question. This may be the case, since C99 is
cleaved directly below the residues involved in cholesterol binding.
Therefore, cholesterol binding might preserve the C99 structure neces-
sary for cleavage by the γ-secretase or acts as a molecular “glue” be-
tween C99 and the γ-secretase. The γ-secretase appears to cleave
both dimeric and monomeric C99 substrates, while the cleavage of mo-
nomeric proteins alters the distribution of different amyloid β peptides
that are generated [110,158,180,181]. While dimerization of C99 does
not conﬂict with the observations made and also does not affect γ-
secretase cleavage [180,181], cholesterol binding to C99 might directly
activate γ-secretase cleavage [150] and at the same time directly in-
hibits α-secretase cleavage [182].
3. Summary: How could lipids control oligomerization of TM
helices?
Tight binding of speciﬁc lipids to large, polytopic MPs is well de-
scribed and it is clear that such lipids are intrinsic and essential parts
of theMP structure, crucial for the stability and activity of theMP. Effects
of global lipid properties, such as the hydrophobic thickness, the lipid
head group chemistry, lipid asymmetry or the lateral pressure proﬁle
on the interaction of simple, single-span TM proteins have also beenanalyzed to some extent in the past decade. In contrast, binding of de-
ﬁned lipid species to individual TM helices has moved into the research
focus only recently, and regulation of TM helix monomer–oligomer
equilibria by binding of deﬁned lipids is a concept, which has emerged
only lately.
Lipids bind to single-span MPs, both in the juxta-membrane region
as well as in the hydrophobic membrane core. The lipid head groups
typically bind via electrostatic interactions and hydrogen bond forma-
tion at the membrane surface to the protein. Especially negatively
charged lipid head groups appear to be recognized and bound by the
extra-membrane regions following individual TM helices. However, in
several cases – potentially in all cases – also the acyl chains of a given
lipid bind to cavities at the surface of a TMhelix viaVan derWaals inter-
actions. On the surface of the p24 and the C99 protein, regions have
been identiﬁed, which allow deﬁned packing of the hydrophobic lipid
moieties. Nevertheless, an acyl chain region can hardly determine spec-
iﬁcity in binding of a diacyl membrane lipid. Only the acyl chain length
and/or the degree of saturation are possible determinants for speciﬁcity.
Thus, it appears to be likely thatmany different lipidswith identical acyl
chains can transiently bind to a given TM helix but only lipids with both
the correct acyl chain and head group bind more tightly and reside at a
TM helix surface for a longer time span. In the case of cholesterol, bind-
ing of the hydrophobic region might already be highly speciﬁc and de-
ﬁned interactions in the hydrophilic region potentially stabilize the
bound lipid.
As summarized here, lipid binding to single-span TM helices can af-
fect the equilibrium between TM helix monomers and higher ordered
oligomers. Some interactions counteract oligomerization and in other
cases, lipid binding appears to enhance oligomerization. As reversible
oligomerization is involved in activation of many MPs, binding of de-
ﬁned lipids to single-span TM proteins might be a mechanism to regu-
late and/or ﬁne-tune the protein activity. But how could lipid binding
trigger the activity of a protein? How can binding of a single lipid mol-
ecule to a TM helix affect the structure of a TM helix oligomer, and con-
sequently its signaling state?
The thus far analyzed and here discussed examples of lipid-binding
single-span TMproteins highlight some common grounds to be consid-
ered in further studies as well as in the design of novel lipid-binding TM
sequences (Fig. 7).
1. It still is completely unclear, at which stage TM helix oligomerization
and lipid binding eventually compete. Lipids could either bind to a
preformed oligomer and thereby stabilize or weaken a TM helix–
helix interaction. Alternatively, lipids bind to monomeric proteins
and thereby either stabilize the monomeric state or generate an
oligomerization-competent monomer. Cholesterol more likely
binds to the monomeric C99 protein and thereby hinders formation
of TM helix–helix contacts.
2. Binding of negatively charged lipid head groups to stretches of basic
amino acids could simply shield clusters of positive charges, decreas-
ing repulsion of positively charged protein regions. Thereby, the pos-
itive free energy term caused by the repulsion is diminished,
resulting in increased stability of a TM helix oligomer.
3. If binding of a lipid head group is mediated by amino acids located
on two different proteins, i.e., if the lipid-binding domain is
formed by two different proteins, binding of a lipid would result
in formation of a dimeric structure. E.g., in the case of the bacterial
light-harvesting proteins, where two individual TM helices interact
with pigments, individual pigments intercalate between the two
individual TM helices and thereby stabilize the dimeric structure [183,
184]. Similarly, a bound lipid could act as molecular “glue”. This might
occur in the soluble domains, but promoting and stabilizing TMhelix–
helix interactions in the hydrophobic TM region are also possible.
Intercalation of individual lipids between different proteins is well
described in the case of large, polytopic TM protein complexes [67].
4. As shown in the case of the Kir2 K+ channels, binding of a lipid head
Fig. 7. Lipid binding inﬂuences TMhelix oligomerization. Themonomer–oligomer equilib-
rium of TM helices might be affected by lipid binding in different ways. (1) Lipids could
bind to themonomeric or the oligomericMPs, and lipid binding could promote or prevent
oligomerization. (2) Lipid binding to positively charged amino acids could shield clusters
of positive charges and could be involved in the proper positioning of a TM helix within
themembrane plane. (3) A lipid-binding cavitymight be formed in between two separate
proteins, and thus the lipid could act as a molecular “glue”. (4) Interaction of protein do-
mains with a lipid can induce structural re-arrangements, preventing or promoting TM
helix–helix interactions. (5) When a lipid-binding site overlaps with a dimerization
motif, helix–helix interactions directly compete with helix–lipid interactions. (6) Lipid
binding to a TM helix can inﬂuence the structural dynamics of a TM helix, which impacts
TM helix–helix interactions. For further details see the text. The numbers refer to the re-
spective categorization discussed in Section 3.
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mational change in the extra-membranous regions, which results in
reorganization of soluble domain interactions, altered steric con-
straints and ﬁnally in altered TM helix–helix interactions. This
can then lead to the formation of a TM helix oligomer with an al-
tered structure, favor formation of a TM helix oligomer or drive
monomerization of an oligomer.
5. If a lipid binds in a TM region, which is also involved in TM helix
oligomerization, as e.g., observed in the case of the C99 TM helix
dimer, lipid binding directly competes with TM helix oligomeriza-
tion and thus, the local concentration of a lipid triggers the oligo-
meric state.
6. Lipid binding to a surface of a TM helix, which is not involved in
formation of TM helix–helix contacts, might induce structural
alterations in the TM helix, resulting in increased or diminished
interaction propensities. Lipid binding could alter the helix ﬂexi-
bility, which might be required for stable TM helix–helix contacts.
Alternatively, lipid binding could affect bending of a helix, which
eventually also affects interaction propensities.
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